The Ensuring Patient Access to Critical Breakthrough Products Act of 2024 (HR1691) was approved by the US House Committee on Ways & Means on 27 June, supported by an amendment that tightened the criteria for breakthrough devices to be covered by the pathway.
Amendments To Breakthrough Device Coverage Act Push Bill Out Of House Ways And Means Committee
The amendment introduced to the Ensuring Patient Access to Critical Breakthrough Products Act in the Ways and Means committee markup of helped usher the legislation to a passing vote.
